LON:AOM - Activeops PLC
Executive Summary
ActiveOps PLC is a UK-listed software company that sells a workforce management (WFM) platform on a subscription basis, primarily to large contact centre and back-office operations in financial services, healthcare, and retail. The platform covers scheduling, attendance, performance analytics, and compliance reporting, and the company occupies a defensible niche in regulated industries where manual spreadsheet-based scheduling remains common. Listed on the London Stock Exchange's AIM market, the group is small in absolute terms but commands a focused share of its target vertical.
The investment case rests on the delivery of management's GBP 100m annual recurring revenue (ARR) target, supported by the recently acquired Enlighten business and the nine new enterprise wins disclosed at the full-year results. The principal near-term catalyst is the next interim results print, which should provide a first read on the integration of Enlighten and the durability of the 119% net revenue retention figure cited by the company. The primary risk is competitive: as ARR scales towards GBP 100m, larger human capital management vendors such as Workday or UKG may elect to target the contact centre segment more aggressively, eroding pricing power and slowing land-and-expand motion.
BUY. Conviction Score: 66/100. The call would be downgraded if Enlighten integration metrics disappoint, ARR growth decelerates below the trajectory implied by the GBP 100m target, or a major customer churn event is disclosed in a regulatory announcement.
Business Model
ActiveOps generates revenue primarily through annual software subscriptions to its workforce management platform, sold on a per-agent-seat or per-module basis under multi-year contracts, typically ranging from one to three years. The customer base is concentrated in highly regulated end markets - large banks, insurers, healthcare trusts, and retail organisations - where the platform's compliance, scheduling, and analytics capabilities displace legacy spreadsheet-based processes. This customer mix produces recurring revenue with high renewal rates and supports a land-and-expand commercial model: clients typically begin with a single module (most commonly scheduling) before adopting additional capabilities over time, lifting average contract value.
Recurring revenue dominates the income statement. Full-year results disclosed ARR of GBP 41.5m, up 46% year-on-year, with net revenue retention of 119% indicating that existing customers expanded spend materially even before counting new logo wins. The Enlighten acquisition, completed in the prior reporting period, added adjacent decision-support and back-office workload management capability and contributed to reported revenue scale but also brought GBP 1.2m of one-off restructuring costs that weighed on reported earnings. Net margin was reported at 4.41% with return on equity of 0.01% in the most recent disclosure, figures distorted by acquisition-related exceptionals rather than core operating economics. Pricing is set per seat or per module, giving the business a degree of operating leverage as customer headcount grows within existing accounts.
The competitive moat is narrow but real. ActiveOps serves a specific vertical - large contact centre and back-office workforces - with deep domain functionality, particularly around regulatory compliance and shift optimisation. Switching costs are meaningful once a customer is live, given the integration with workforce data and operational processes. The moat is, however, narrow in absolute terms: the platform sits adjacent to the broader human capital management suites offered by much larger vendors, and scale remains the principal vulnerability rather than product quality.
Financial Snapshot
Recent Catalysts
[June 2026] - ActiveOps disclosed full-year trading update figures showing record ARR of GBP 41.5m, up 46% year-on-year, alongside nine new enterprise customer wins and reaffirmed progress towards the GBP 100m ARR target. Source: Investegate (Company Announcement / RNS).
[2026] - The company completed the integration of Enlighten, which was acquired in the prior reporting period, with GBP 1.2m of restructuring costs incurred during the integration process. Source: Investegate (Company Announcement / RNS).
[February 2026] - Insider purchase disclosed, with Richard John Jeffery acquiring 54 shares of ActiveOps stock, recorded in regulatory insider transaction filings. Source: Defence World (citing regulatory disclosure).
[January 2026] - ActiveOps reported quarterly EPS of GBX (1.31), with shares moving down 1.6% on the day amid broader sector weakness, as covered by equity news wires. Source: The Markets Daily.
Thesis Evaluation
Bull Case (33% weight)
ARR compounds toward the GBP 100m target, Enlighten cross-sell accelerates, and net revenue retention holds above 115%, attracting a sector rerating. Analyst consensus sits near 310p and a fully realised bull scenario would target 340p over the next twelve months.
Base Case (51% weight)
ARR grows at a mid-30s percentage pace to roughly GBP 55 - 60m, Enlighten contributes incremental recurring revenue but no transformational uplift, and net revenue retention normalises towards 110%. This produces a twelve-month target of 240p, ahead of the current 198.77p but below consensus.
Bear Case (16% weight)
ARR growth decelerates sharply as larger HCM vendors compete aggressively, a material customer churn event is disclosed, or integration of Enlighten disappoints operationally. In that scenario the shares revisit the 150p area over twelve months.
Key Risks
- Competitive entry by larger HCM vendors: Workday, UKG, or another large human capital management platform elects to target the contact centre segment aggressively, eroding ActiveOps' pricing power and slowing land-and-expand momentum. Estimated probability: 30%. Impact: severe.
- Scale disadvantage: At a sub-GBP 100m ARR base, ActiveOps lacks the R&D and sales investment depth of much larger peers, constraining product modernisation and international expansion. Estimated probability: 40%. Impact: moderate.
- Customer concentration risk: A meaningful share of recurring revenue is concentrated in a limited number of large financial services and healthcare accounts, leaving the top line exposed to single-customer renewal outcomes. Estimated probability: 25%. Impact: severe.
- Acquisition integration risk: The Enlighten integration has already absorbed GBP 1.2m of restructuring costs and any further integration friction could delay synergy realisation and depress near-term margins. Estimated probability: 35%. Impact: moderate.
- AIM listing liquidity and institutional accessibility: Listing on AIM rather than the Main Market limits the pool of institutional capital able to hold the stock, which can amplify price volatility and constrain valuation rerating. Estimated probability: 50%. Impact: moderate.
Who Should Own It / Avoid It
Ideal for: long-term growth investors with a minimum three-year holding horizon, a high tolerance for single-stock volatility, and a willingness to back a small-cap UK software business executing against an explicit ARR milestone. The position suits investors who understand subscription software economics and are comfortable with AIM-listed liquidity characteristics. Conviction should be sized accordingly given the GBP 100m ARR target remains execution-dependent.
Avoid if: investors require immediate dividend income, cannot tolerate single-stock drawdowns of 30% or more, or need daily liquidity for position management. The stock is also unsuitable for investors benchmarked to large-cap, profitable, or dividend-paying equity mandates, as well as those unwilling to underwrite the execution risk associated with management's ARR target against larger, well-capitalised competitors.
Recommendation
BUY - 66/100. The recommendation reflects a constructive view on the full-year results, the quality of disclosed ARR growth, and the operational progress on the Enlighten acquisition, tempered by the scale and competitive risks inherent in a sub-GBP 100m ARR software business. The call would be upgraded towards a higher conviction tier on confirmation that Enlighten cross-sell is contributing materially to ARR, that net revenue retention remains above 115%, and that ARR growth is tracking the trajectory implied by the GBP 100m target. The call would be downgraded if ARR growth decelerates below 25% on a like-for-like basis, if a major customer churn event surfaces in regulatory disclosures, or if integration of Enlighten produces further material exceptional costs. At the current price of 198.77p the shares trade above our buy ceiling of 180.00p: the thesis is credible but the price is not - new positions only below that level.
The probability-weighted value across our three scenarios is 258.60p, 30% above the current price of 198.77p - the market has not yet priced our probability-weighted view. Levels below are derived from the scenario targets and probabilities above, not from percentage offsets to today's price.
below 180.00p - below this level the upside to the base-case target (240.00p) is at least 2x the downside to the bear case (150.00p), the minimum risk/reward we require before committing new capital.
between 180.00p and 240.00p - the base case is not yet fully priced, so existing holders are paid to wait, but new money gets no margin of safety in this zone.
above 240.00p - at this level the base case is fully reflected in the price and anything beyond it is paying for a bull scenario we weight at 33%.
if the investment thesis is invalidated if ARR growth decelerates below 20% year-on-year on a like-for-like basis, a major named customer is disclosed as churned in a regulatory announcement, or a dilutive equity raise is required to fund operations, regardless of price - the bear target of 150.00p is the backstop, not an arbitrary percentage stop.
Conviction Trend
Latest conviction: 66/100. Trend versus prior report: Down.
| Report date | Conviction |
|---|---|
| 2026-08-01 | 29 |
| 2026-07-25 | 54 |
| 2026-06-28 | 59 |
| 2026-05-30 | 73 |
| 2026-04-28 | 59 |
Sources
Market data: DYOR HQ proprietary market data workflow.
Public sentiment and news flow: Public news flow was drawn from company-issued regulatory announcements disseminated via Investegate and the London Stock Exchange news service, equity news wires covering share price action, and third-party commentary summarising publicly disclosed financial metrics and insider transactions.
Primary source types: Company press releases and RNS announcements, regulatory insider transaction disclosures, company investor relations materials, and third-party research summarising publicly filed financial data were the principal source categories consulted in preparing this report.
Key sources
- ACTIVEOPS PLC - Full Year Results | Investor Meet Company
- ActiveOps delivers strong ARR growth as Enlighten acquisition boosts global expansion (AOM)
- Activeops PLC (AOM:LSE) Share price, analysis ...
- ACTIVEOPS PLC (AOM) Stock, Price, News, Quotes ...
- (AOM.L) | Stock Price & Latest News
- ActiveOps Plc News - ADVFN UK
- Top ActiveOps (AOM) Competitors 2026
- ActiveOps - Market Share, Competitor Insights in Workforce Management
- ActiveOps Sets Date for Full-Year Results and Investor Briefings
- Notice of Results | Company Announcement | Investegate
Data correct as of 2026-08-01.